TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

28.10$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Avalyn Pharma Inc. (AVLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AVLN
Line item Q1 25 Q2 25 Q1 26 Q2 26
-19 -21 -30 -26
0.0 0.0 0.1 0.1
0.5 1.1 1.2 2.8
-1.8 -1.2 -4.2 0.0
0.0 0.0 0.3 0.3
– – 55 -119
0.0 0.0 15 0.0
0.0 90 15 317
4.8 33 40 172
-19 -21 -30 -26

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?